Stocktoria
QuidelOrtho Corp QDEL
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1991-02-01
Chart by TradingView
5/9
Piotroski F — financial health
-0.56
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $2.7B | $2.8B | $3.0B | $3.3B | $1.7B |
| Operating income | -$919.2M | -$2.0B | $139.1M | $843.7M | $906.0M |
| Net income | -$1.1B | -$2.1B | -$10.1M | $548.7M | $704.2M |
| Operating cash flow | $105.2M | $83.0M | $280.2M | $885.3M | $805.9M |
| Free cash flow | -$83.0M | -$112.1M | $70.9M | $744.4M | $513.1M |
| Total assets | $5.8B | $6.4B | $8.6B | $8.9B | $2.4B |
| Total liabilities | $3.8B | $3.4B | $3.6B | $3.9B | $501.0M |
| Shareholders' equity | $1.9B | $3.0B | -$30.0M | -$67.6M | $1.9B |
| Ratios | |||||
| Operating margin | -33.7% | -70.5% | 4.6% | 25.8% | 53.3% |
| Net margin | -41.5% | -73.7% | -0.3% | 16.8% | 41.5% |
| FCF margin | -3.0% | -4.0% | 2.4% | 22.8% | 30.2% |
| Return on assets | -19.6% | -31.9% | -0.1% | 6.2% | 29.0% |
| Return on equity | -58.9% | -68.8% | 33.7% | -811.7% | 36.5% |
| Debt / equity | 1.40× | 0.83× | -80.75× | -39.18× | — |
| Current ratio | 1.50 | 1.22 | 1.57 | 1.56 | 4.45 |
| Revenue growth | -1.9% | -7.2% | -8.2% | 92.3% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 762,169 | $12.5M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.56 (distress)
- Working capital / assets 0.083
- Retained earnings / assets -0.173
- EBIT / assets -0.159
- Equity / liabilities 0.499
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001906324 · as of 2025-12-28. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.